Axsome Therapeutics, Inc. - Common Stock (NQ:AXSM)

176.81 -2.44 (-1.36%)

Delayed Quote Updated: 10:11 AM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Axsome Therapeutics, Inc. - Common Stock

< Previous 1 2

...

15 16 17 18 19 20 21 22 23

...

26 27 Next >

2 Top Biotech Stocks to Buy for the Long Haul ↗

October 28, 2022

Both drugmakers have outperformed the market in the past year.

Via The Motley Fool

Axsome Therapeutics to Ring the NASDAQ Stock Market Opening Bell Today

October 27, 2022

From Axsome Therapeutics, Inc.

Via GlobeNewswire

Got $500? Buy These 2 Unstoppable Stocks ↗

October 26, 2022

Invest in these stocks if your priority is long-term growth.

Via The Motley Fool

Axsome Therapeutics to Report Third Quarter 2022 Financial Results on November 7, 2022

October 21, 2022

From Axsome Therapeutics, Inc.

Via GlobeNewswire

Axsome Therapeutics Announces Availability of AUVELITY™, the First and Only Oral NMDA Receptor Antagonist for the Treatment of Major Depressive Disorder in Adults

October 20, 2022

From Axsome Therapeutics, Inc.

Via GlobeNewswire

Better Buy: Moderna vs. Axsome Therapeutics ↗

October 10, 2022

Both of these biotechs offer exciting future prospects.

Via The Motley Fool

Why Otonomy Shares Dipped By Around 54%; Here Are 67 Biggest Movers From Yesterday ↗

October 14, 2022

Gainers Nutex Health Inc. (NASDAQ: NUTX) jumped 72.4% to settle at $0.9551 on Thursday. Nutex Health recently provided a corporate update.

Via Benzinga

Albertsons Companies, Domino's Pizza And Other Big Gainers From Thursday ↗

October 14, 2022

U.S. stocks closed higher on Thursday, with the Dow Jones jumping over 800 points. Here is the list of some big stocks recording gains in the previous session.

Via Benzinga

Axsome Therapeutics' Sunosi Improves Cognitive Function In Patients With Sleep Disorder ↗

October 03, 2022

Via Benzinga

8 Analysts Have This to Say About Axsome Therapeutics ↗

September 30, 2022

Analysts have provided the following ratings for Axsome Therapeutics (NASDAQ:AXSM) within the last quarter:

Via Benzinga

COLA 2023: How Much Did Social Security Benefits Increase for 2023? ↗

October 13, 2022

Social Security is increasing for 2023 as the Social Security Administration announces an update to the Cost-of-Living Adjustment (COLA).

Via InvestorPlace

Why Is Axsome Therapeutics (AXSM) Stock Up Today? ↗

October 13, 2022

Sometimes, company shares can catch a bid when a rival gets bad news. That's happening with Axsome today as AXSM stock moves higher.

Via InvestorPlace

Why Laser Photonics Shares Are Trading Higher By Around 44%, Here Are 50 Stocks Moving In Thursday's Mid-Day Session ↗

October 13, 2022

Gainers FedNat Holding Company (NASDAQ: FNHC) shares jumped 89% to $0.4242 after dipping 34% on Wednesday.

Via Benzinga

Relmada Tanks After 'Paradoxical Results' Undermine Depression Drug; Axsome Surges ↗

October 13, 2022

The company noted "paradoxical results" where the placebo, at times, topped the drug.

Via Investor's Business Daily

Why Relmada Therapeutics Shares Are Trading Lower By 84%; Here Are 23 Stocks Moving Premarket ↗

October 13, 2022

Gainers Laser Photonics Corporation (NASDAQ: LASE) shares rose 45% to $4.24 in pre-market trading. Laser Photonics announced that Coca-Cola recently completed the implementation of its first CleanTech...

Via Benzinga

Delta Air Lines, Walgreens Boots Alliance And Some Other Big Stocks Moving Higher In Today's Pre-Market Session ↗

October 13, 2022

U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session.

Via Benzinga

3 Red-Hot Stocks That Could Continue to Beat the Market ↗

October 13, 2022

Investors are betting on these companies' revenue growth prospects.

Via The Motley Fool

Got $1,000? These 3 Stocks Could Double Your Money in 5 Years. ↗

October 12, 2022

All three stocks are worth keeping a lot longer than half a decade.

Via The Motley Fool

Missed Out On Axsome Therapeutics? My Best Biotech Stock to Buy and Hold ↗

October 12, 2022

Vertex already generates billions in revenue -- but there may be more to come.

Via The Motley Fool

Axsome Therapeutics Voices its Commitment to Mental Health on World Mental Health Day 2022

October 10, 2022

From Axsome Therapeutics, Inc.

Via GlobeNewswire

These 7 Biotech Stocks Are Set to Boom in 2023 ↗

October 10, 2022

This article looks at seven biotech stocks that look like good options to move significantly higher in 2023

Via InvestorPlace

If You Invested $5,000 in Axsome Therapeutics in 2019, This Is How Much You Would Have Today ↗

October 08, 2022

Could the stock keep performing?

Via The Motley Fool

Jim Cramer On This Industrial Stock: 'You Don't Know What's In It' ↗

October 07, 2022

On CNBC’s "Mad Money Lightning Round," Jim Cramer recommended buying Sociedad Quimica y Minera de Chile (NYSE: SQM) as "fertilizer’s in short supply and so is lithium."

Via Benzinga

3 Stocks Savvy Investors Are Buying Hand Over Fist ↗

October 06, 2022

These high-flying stocks are defying the bear market.

Via The Motley Fool

Axsome Therapeutics Announces Sunosi® (Solriamfetol) Meets Primary Endpoint Demonstrating Improvement in Cognitive Function in the SHARP Trial in Cognitively Impaired Patients with Excessive Daytime Sleepiness Associated with Obstructive Sleep Apnea

October 03, 2022

From Axsome Therapeutics, Inc.

Via GlobeNewswire

10 Health Care Stocks Whale Activity In Today's Session ↗

September 29, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

Axsome Therapeutics Announces Plans to Resubmit AXS-07 NDA Based on Successful FDA Type A Meeting

September 29, 2022

From Axsome Therapeutics, Inc.

Via GlobeNewswire

These Were the Five Best And Worst Performing Mid-Cap Stocks In August 2022 ↗

September 20, 2022

We have used the August return data from finviz.com to come up with the five best and worst performing mid-cap stocks in August 2022.

Via Talk Markets

7 Top-Rated Biotech Stocks to Buy for Q4 ↗

September 15, 2022

A new White House program makes these seven names some outstanding biotech stocks to buy for the fourth quarter.

Via InvestorPlace

Biotech Stocks Stand to Benefit as Biden Announces Support for Industry ↗

September 12, 2022

President Biden has announced a new initiative to help U.S. biotech producers grow. Here's what this news means for biotech stocks.

Via InvestorPlace

< Previous 1 2

...

15 16 17 18 19 20 21 22 23

...

26 27 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.